Search results for: 'analyst ad cell'

05 Aug 2024  |  Global  |  Technology Research

CGT Research Outlook and Technology Growth Opportunities

CGT Landscape Assessment

Infographics

×

The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...

There are numerous companies developing immunotherapy approaches to treat cancer, autoimmune and several other diseases. Current study describes some of the recent advances in immunotherapy, mostly cancer. These include refined cell therapies, stem cell applications in cancer treatment, monoclonal, polyclonal and bispecific antibodies. Some of exci...

Companies that are investing in the renewable energy sector are looking for the energy type that will lead the 'Green Revolution'. This analysis will take an in-depth view into this issue and highlight how solar energy will compete in the global market. Several companies that participate in the semiconductor and surface mount technology equipment m...

The study analyses the global pump services market across various industries. With new pump projects on hold, there will be greater demand for pump services. Analysis is provided by type of pump service (MRO, installation and commissioning, decommissioning, and value added services). Geographic trends across four regions (North America, EMEA, APAC,...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

This Frost & Sullivan research service titled Colombian Total Telecommunications Services Market and New Opportunities for Operators, Forecast to 2024, provides market sizing and forecasts by segment and technology, both in terms of lines and revenue, as well as market share figures. In this research, Frost & Sullivan's expert analysts thoroughly e...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...